Built for PSX investors
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.

Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.



Citi Pharma Limited's annual report cover is provided. The announcement metadata identifies this as transmission of the annual report for the year ended June 30, 2026; the supplied pages do not show further report details.
Citi Pharma Limited published notice of its Annual General Meeting, scheduled for October 28, 2026 at 12:30 p.m. at its head office in Lahore, with participation available through video link. The meeting will consider the audited financial statements for the year ended June 30, 2026, along with other ordinary business.
Citi Pharma Limited will hold its Annual General Meeting at 12:30 p.m. on October 28, 2026, at its head office in Lahore. Shareholders will consider the audited financial statements for the year ended June 30, 2026, and the Board has recommended no dividend for the year. The share transfer books will remain closed from October 22 through October 28, 2026.
Citi Pharma Limited announced audited financial statements for the year ended June 30, 2026. In the consolidated results, revenue increased to Rs. 14.076 billion and operating profit to Rs. 1.940 billion, while profit for the year declined to Rs. 790.334 million from Rs. 892.039 million and EPS fell to Rs. 3.46 from Rs. 3.90.
A meeting of the Board of Directors is scheduled to discuss the Annual Audited Financial Results and other entitlements.
The minutes of the Extraordinary General Meeting were confirmed, and a special resolution was approved to alter the Memorandum of Association to enable operations related to cannabis.
Citi Pharma Limited has issued a notice for an Extraordinary General Meeting to be held on September 18, 2026, regarding the alteration of the Memorandum of Association.
Rizwan Ahmad, an Executive Director, executed a buy transaction involving 200,000 shares.
Citi Pharma Ltd (CPHL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. Read company disclosures, financial-result notices, corporate actions and meeting updates. Open the relevant notice for its dates and terms.
This page brings together available disclosures for Citi Pharma Ltd (CPHL), including results, corporate actions, meeting notices and other company updates. Open an individual announcement to read its details and available source document.
Look for the relevant financial-result or corporate-action announcement. Check its reporting period, dividend amount and any conditions in the notice; publication date is not necessarily the payment or entitlement date.
A future date should only be taken from an announcement that explicitly states it. Past payment dates or a historical dividend yield do not establish the next payout or book-closure schedule.
Use the Fundamentals section for available earnings, dividend and valuation figures, keeping each reporting period in view.
CPHL financial results and fundamentalsPSX guides
What results, payouts, board meetings and other PSX disclosures mean for investors.

A practical PSX company research checklist for beginners: read stock pages, fundamentals, charts, technicals, announcements, annual reports and market news before buying.
Read guide
A plain-English guide to how capital gains tax (CGT) and dividend tax work on Pakistan Stock Exchange shares - filer vs non-filer rates, how holding period and acquisition date matter, how NCCPL collects CGT, and what you still have to declare.
Read guide
A beginner-friendly PSX guide comparing dividend stocks and growth stocks, including risks, investor fit, sectors, interest rates and market cycles.
Read guideData source: Market data is provided under a Pakistan Stock Exchange data license held by Recube Technologies (investify.pk), listed on the official PSX services page. Quotes, charts and derived figures are for information only and may be delayed, adjusted or revised by the exchange.
Not financial advice: Investify is not a brokerage and does not provide investment, trading or financial advice. Nothing on this page is a recommendation to buy or sell any security. Do your own research or consult a licensed advisor before making investment decisions. Read our data & editorial policy.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
